Literature DB >> 2442069

Expression of biologically active human T-cell lymphotropic virus type III reverse transcriptase in Bacillus subtilis.

S F Le Grice, V Beuck, J Mous.   

Abstract

A 2.4-kb DNA fragment from the pol region of the human T-cell lymphotropic virus, encoding the protease, reverse transcriptase and a portion of the endonuclease N-terminus was stably introduced into a high-level Bacillus subtilis expression system under inducible control of the Escherichia coli lac regulatory elements. The major expression plasmid, pRTL11, contains a bacteriophage T5 promoter/lac operator element, which is controlled by lac repressor, supplied by the secondary plasmid, pBL1. Upon IPTG induction, a 90-kDa polyprotein is synthesised and subsequently proteolytically cleaved to reveal 64-kDa and 52-kDa polypeptides. Partial purification reveals that reverse transcriptase activity co-migrates with these two polypeptides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442069     DOI: 10.1016/0378-1119(87)90252-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  17 in total

1.  Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases.

Authors:  D D Loeb; C A Hutchison; M H Edgell; W G Farmerie; R Swanstrom
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

2.  A single 66-kilodalton polypeptide processed from the human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity.

Authors:  S F Le Grice; R Zehnle; J Mous
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

3.  Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma.

Authors:  H König; E Behr; J Löwer; R Kurth
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

4.  Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.

Authors:  V R Prasad; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural DNA.

Authors:  J Weber; F Grosse
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

6.  Expression of luciferase genes from different origins in Bacillus subtilis.

Authors:  J Lampinen; L Koivisto; M Wahlsten; P Mäntsälä; M Karp
Journal:  Mol Gen Genet       Date:  1992-04

7.  Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59).

Authors:  R Rautemaa; G A Jarvis; P Marnila; S Meri
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

8.  Nitric oxide donor-mediated killing of bioluminescent Escherichia coli.

Authors:  M Virta; M Karp; P Vuorinen
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

9.  Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds.

Authors:  V Loimaranta; J Tenovuo; L Koivisto; M Karp
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Recombinant luminescent bacteria for measuring bioavailable arsenite and antimonite.

Authors:  S Tauriainen; M Karp; W Chang; M Virta
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.